NUVL Nuvalent Inc - Ordinary Shares - Class A
238
$71.36
$0.48
(0.68%)
| Watchers | 238 |
| 52-Wk Low | $38.14 |
| 52-Wk High | $89.39 |
| Market Cap | $4.58B |
| Volume | 105,472.00 |
| 52-Wk High | $89.39 |
| 52-Wk Low | $38.14 |
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655PR Newswire • 4 days ago
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 PR Newswire CAMBRIDGE, Mass., May 16, 2024 CAMBRIDGE...
Share to Feed
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated...
Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024 Nuvalent Presents New...
Related Stocks: NUVL...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Nuvalent, Inc. (NASDAQ:NUVL - Get Free Report) insider Deborah Ann Miller sold 22,000 shares of the business's stock in a transaction dated Thursday, March 28th. The stock was sold at an average...
Related Stocks: NUVL...
Nuvalent, Inc. (NASDAQ:NUVL Get Free Report) has been given a consensus recommendation of Moderate Buy by the nine brokerages that are covering the firm, MarketBeat.com reports...
Ellsworth Advisors LLC trimmed its position in shares of Nuvalent, Inc. (NASDAQ:NUVL Free Report) by 4.4% during the 4th quarter, according to its most recent Form 13F filing with the...